RCAMU
ALXN

Rothschild & Co Asset Management US’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Rothschild & Co Asset Management US’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,319
Closed -$647K – 567
2017
Q2 		$647K Buy
+5,319
New +$647K 0.01% 423